Albania’s pharmaceutical sector holds great potential to further strengthen national health security and bring about innovations that improve lives.
Uka Group believes it can play a proactive role in this vital domain moving forward by investing and transferring expertise into the country’s healthcare system. This may involve developing supply chains that increase access to essential medicines as well as supporting domestic pharma companies that deliver cutting-edge therapies.
While we do not yet have specific plans in place for the pharmaceutical space, we look forward to closely evaluating partnership and investment opportunities that accelerate access and innovation in the life sciences arena locally.
Uka Group aims to be a change-enabling partner in elevating Albania’s capabilities across the pharmaceutical value chain over the long run – from R&D to enhancing delivery infrastructure and patient outcomes.